Picomolar concentrations of hibernation induction delta opioid peptide [D-Ala2,D-Leu5]enkephalin increase the nerve growth factor in NG-108 cells

Synapse

Volumn 57, Issue 3, 2005, Pages 179-181

  Tsai, Shang Yi ^a   Hayashi, Teruo ^a   Su, Tsung Ping ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

c Fos; c Jun; Dadle; NG 108; NGF; opioid

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; NERVE GROWTH FACTOR; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; HIBERNATION; IMMUNOREACTIVITY; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, LEUCINE-2-ALANINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLIOMA; MICE; NERVE GROWTH FACTOR; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS;

EID: 22544432818     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20167     Document Type: Article

References (16)

1. Belcheva MM, Barg J McHale RJ, Gao XM, Chuang DM, Coscia CJ. 1991. Upregulation of delta opioid receptors in neuroblastoma hybrid cells: evidence for differences in the mechanisms of action of sodium butyrate and naltrexone. J Pharmacol Exp Ther 259:302-309.
2. Borlongan CV, Skinner SJM, Geaney M, Vasconcellos AV, Elliott RB, Emerich DF. 2004a. Intracerebral transplantation of porcine choroid plexus provides structural and functional neuroprotection in a rodent model of stroke. Stroke 35:2206-2210.
3. Borlongan CV, Wang Y, Su TP. 2004b. Delta opioid peptide (D-Ala2,D-Leu5)enkephalin: linking hibernation and neuroprotection. Front Biosci 9:3392-3398.
4. Hayashi T, Tsao LI, Su TP. 2002. Antiapoptotic and cytotoxic properties of delta opioid peptide [D-Ala2,D-leu5]enkephalin in PC12 cells. Synapse 43:86-94.
5. Hayashi T, Su TP. 2003. Chronic [-Ala2, -Leu5]enkephalin treatment increases the nerve growth factor in adult mouse brain. Eur J Pharmacol 19:237-239.
6. 2+ concentration. J Pharmacol Exp Ther 293:788-798.
7. Hengerer B, Lindholm D, Heumann R, Ruther U, Wagner EF, Thoenen H. 1990. Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc Natl Acad Sci USA 87:3899-3903.
8. Ignatova EG, Belcheva MM, Bohn LM, Neuman MC, Coscia CJ. 1999. Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: biochemical and immunofluorescence confocal microscopic evidence. J Neurosci 19:56-63.
9. Oeltgen PR, Nilekani SP, Nuchols PA, Spurrier WA, Su TP 1988. Further studies on opioids and hibernation: delta opioid receptor ligand selectively induced hibernation in summer-active ground squirrels. Life Sci 43:1565-1574.
10. Salinas M, Diaz R, Abraham N, Ruiz de Galarreta CM, Cuadrado A. 2003. Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3 kinase-dependent manner. J Biol Chem 278:13898-13904.
11. Sofroniew IMV, Howe CL, Mobley WC. 2001. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24:1217-1281.
12. Tencheva ZS, Belcheva MM, Velichkova AA, Lissichkova EG, Coscia CJ. 1997. Opioid regulation of AP-1 DNA-binding activity in NG108-15 cells under conditions of opioid-receptor adaptation. Mol Brain Res 48:156-158.
13. Tenconi B, Lesma E, DiGiulio AM, Gorio A. 1996. High opioid doses inhibit whereas low doses enhance neuritogenesisi in PC12 cells. Brain Res Dev Brain Res 94:175-181.
14. Torregrossa MM, Isgor C, Folk JE, Rice KE, Watson SJ, Woods JH. 2004. The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats. Neuropsychopharmacology 29:649-659.
15. Tsao LI, Su TP 2001. Hibernation-induction peptide and cell death: delta opioid peptide [D-Ala2,D-Leu5]enkephalin potently blocks Bax-related apoptotic processes. Eur J Pharmacol 428:149-151.
16. Tsao LI, Ladenheim B, Andrews AM, Chiueh CC, Cadet JL, Su TP 1998. Delta opioid peptide [D-Ala2,D-leu5]enkephalin blocks the long-term loss of dopamine transporters induced by multiple administrations of methamphetamine: involvement of opioid receptors and reactive oxygen species. J Pharmacol Exp Ther 287:322-331.